2024 annual financial data
Spruce Biosciences 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,139.56%.
Operating income was -56,151,000 USD and net income was -53,036,000 USD.
Operating cash flow was -55,964,000 USD.
Get free Spruce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,911,000 USD
- Operating income
- -56,151,000 USD
- Net income
- -53,036,000 USD
- Operating cash flow
- -55,964,000 USD